Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Sachmechi I, Vahedi M, Nalamasu S, Vuppalanchi R. Interrelationship between thyroid nodularity and TSH level. Mt Sinai J Med. 2005 Jan;72(1):33-5. PubMed PMID: 15682260.
Vuppalanchi R, Teal E, Chalasani N. Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes. Am J Med Sci. 2005 Feb;329(2):62-5. doi: 10.1097/00000441-200502000-00002. PubMed PMID: 15711421.
Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol. 2005 Mar;39(3):237-42. doi: 10.1097/01.mcg.0000152747.79773.2f. PubMed PMID: 15718867.
Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. J Clin Endocrinol Metab. 2006 Jun;91(6):2279-85. doi: 10.1210/jc.2006-0075. Epub 2006 Apr 4. PubMed PMID: 16595594.
Vuppalanchi R, Chalasani N. Statins for hyperlipidemia in patients with chronic liver disease: are they safe?. Clin Gastroenterol Hepatol. 2006 Jul;4(7):838-9. doi: 10.1016/j.cgh.2006.04.020. PubMed PMID: 16829348.
Vuppalanchi R, Chalasani N. Multicenter timolol study: the value of timolol and hemodynamic monitoring in the management of portal hypertensive cirrhotics with no esophageal varices. Gastroenterology. 2006 Aug;131(2):674-6; discussion 676. doi: 10.1053/j.gastro.2006.01.090. PubMed PMID: 16890623.
Vuppalanchi R, Chalasani N, Saxena R. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide. Am J Surg Pathol. 2006 Dec;30(12):1619-23. doi: 10.1097/01.pas.0000213342.78475.48. PubMed PMID: 17122520.
Vuppalanchi R, Vakili ST, Kahi CJ. Isolated melanosis of the gastric antrum: an unusual endoscopic finding. Clin Gastroenterol Hepatol. 2007 Jan;5(1):e2. doi: 10.1016/j.cgh.2006.09.020. Epub 2006 Dec 4. PubMed PMID: 17142108.
Vuppalanchi R, Cummings OW, Saxena R, Ulbright TM, Martis N, Jones DR, Bansal N, Chalasani N. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. J Clin Gastroenterol. 2007 Feb;41(2):206-10. doi: 10.1097/01.mcg.0000225515.28536.3a. PubMed PMID: 17245221.
Kolwankar D, Vuppalanchi R, Ethell B, Jones DR, Wrighton SA, Hall SD, Chalasani N. Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity. Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93. doi: 10.1016/j.cgh.2006.12.021. PubMed PMID: 17368239.
Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?. Am J Gastroenterol. 2007 Mar;102(3):558-62; quiz 693. doi: 10.1111/j.1572-0241.2006.01019.x. PubMed PMID: 17156142.
Vuppalanchi R, Chalasani N. Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant?. Gastroenterology. 2007 Apr;132(4):1624-6. doi: 10.1053/j.gastro.2007.02.065. PubMed PMID: 17408645.
Vuppalanchi R. How safe is acetaminophen for the treatment of pain and fever in newly-abstinent patients with alcoholism?. Nat Clin Pract Gastroenterol Hepatol. 2008 Mar;5(3):134-5. doi: 10.1038/ncpgasthep1038. Epub 2008 Jan 15. PubMed PMID: 18212776.
Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 2009 Jan;49(1):306-17. doi: 10.1002/hep.22603. Review. PubMed PMID: 19065650; PubMed Central PMCID: PMC2766096.
Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, Tonascia J, Chalasani N. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol. 2009 Apr;7(4):481-6. doi: 10.1016/j.cgh.2008.12.015. Epub 2008 Dec 25. PubMed PMID: 19162235; PubMed Central PMCID: PMC2770348.
Juluri R, Gupta S, Vuppalanchi R. Serum concentration-dependent hepatotoxicity in individuals receiving oral salsalate. Dig Dis Sci. 2009 Jun;54(6):1375-6. doi: 10.1007/s10620-008-0487-4. Epub 2008 Sep 4. PubMed PMID: 18770032.
Tandra S, Vuppalanchi R. Use of statins in patients with liver disease. Curr Treat Options Cardiovasc Med. 2009 Aug;11(4):272-8. doi: 10.1007/s11936-009-0028-2. PubMed PMID: 19627660.
Bell LN, Theodorakis JL, Vuppalanchi R, Saxena R, Bemis KG, Wang M, Chalasani N. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology. 2010 Jan;51(1):111-20. doi: 10.1002/hep.23271. PubMed PMID: 19885878; PubMed Central PMCID: PMC2903216.
Bell LN, Lee L, Saxena R, Bemis KG, Wang M, Theodorakis JL, Vuppalanchi R, Alloosh M, Sturek M, Chalasani N. Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G746-54. doi: 10.1152/ajpgi.00485.2009. Epub 2010 Feb 18. PubMed PMID: 20167877; PubMed Central PMCID: PMC3774260.
Misra VL, Vuppalanchi R, Jones D, Hamman M, Kwo PY, Kahi C, Chalasani N. The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites. Aliment Pharmacol Ther. 2010 Oct;32(8):1044-50. doi: 10.1111/j.1365-2036.2010.04426.x. PubMed PMID: 20937051; PubMed Central PMCID: PMC3154138.
Vuppalanchi R, Hayashi PH, Chalasani N, Fontana RJ, Bonkovsky H, Saxena R, Kleiner D, Hoofnagle JH. Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network. Aliment Pharmacol Ther. 2010 Nov;32(9):1174-83. doi: 10.1111/j.1365-2036.2010.04449.x. Epub 2010 Sep 3. PubMed PMID: 20815829; PubMed Central PMCID: PMC3773985.
Juluri R, Vuppalanchi R, Olson J, Unalp A, Van Natta ML, Cummings OW, Tonascia J, Chalasani N. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol. 2011 Jan;45(1):55-8. doi: 10.1097/MCG.0b013e3181dd1348. PubMed PMID: 20505526; PubMed Central PMCID: PMC2978283.
Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen J, Mullis D, Kwo P, Chalasani N. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol. 2011 Mar;9(3):254-9. doi: 10.1016/j.cgh.2010.10.035. Epub 2010 Nov 17. PubMed PMID: 21092762; PubMed Central PMCID: PMC3156473.
Berman K, Tandra S, Vuppalanchi R, Ghabril M, Sandrasegaran K, Nguyen J, Caffrey H, Liangpunsakul S, Lumeng L, Kwo P, Chalasani N. Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study. Am J Gastroenterol. 2011 May;106(5):899-906. doi: 10.1038/ajg.2010.477. Epub 2010 Dec 21. PubMed PMID: 21179013.
Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH. Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clin Gastroenterol Hepatol. 2011 Jun;9(6):517-523.e3. doi: 10.1016/j.cgh.2011.02.019. Epub 2011 Feb 26. PubMed PMID: 21356330; PubMed Central PMCID: PMC3718017.
Vuppalanchi R, Juluri R, Ghabril M, Kim S, Thong N, Gorski JC, Chalasani N, Hall SD. Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt. J Clin Gastroenterol. 2011 Aug;45(7):638-42. doi: 10.1097/MCG.0b013e3181f8c522. PubMed PMID: 20962670.
Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Ünalp-Arida A, Wilson LA, Chalasani N. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol. 2011 Sep;55(3):654-659. doi: 10.1016/j.jhep.2010.11.021. Epub 2010 Dec 21. PubMed PMID: 21172393; PubMed Central PMCID: PMC3139780.
Bell LN, Molleston JP, Morton MJ, Klipsch A, Saxena R, Vuppalanchi R, Chalasani N. Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes. J Clin Gastroenterol. 2011 Oct;45(9):800-7. doi: 10.1097/MCG.0b013e31821377e4. PubMed PMID: 21602702; PubMed Central PMCID: PMC5300763.
Vuppalanchi R, Juluri R, Bell LN, Ghabril M, Kamendulis L, Klaunig JE, Saxena R, Agarwal D, Johnson MS, Chalasani N. Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements. Am J Med Sci. 2011 Oct;342(4):314-7. doi: 10.1097/MAJ.0b013e31821d9905. PubMed PMID: 21691193; PubMed Central PMCID: PMC3644215.
Vuppalanchi R, Gould RJ, Wilson LA, Unalp-Arida A, Cummings OW, Chalasani N, Kowdley KV. Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. Hepatol Int. 2012 Jan;6(1):379-85. doi: 10.1007/s12072-011-9277-8. Epub 2011 May 10. PubMed PMID: 21557024; PubMed Central PMCID: PMC3511661.
Chalasani N, Vuppalanchi R, Navarro V, Fontana R, Bonkovsky H, Barnhart H, Kleiner DE, Hoofnagle JH. Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. Ann Intern Med. 2012 Jun 19;156(12):857-60, W297-300. doi: 10.7326/0003-4819-156-12-201206190-00006. PubMed PMID: 22711078; PubMed Central PMCID: PMC3825458.
Chatrath H, Liangpunsakul S, Ghabril M, Otte J, Chalasani N, Vuppalanchi R. Prevalence and morbidity associated with muscle cramps in patients with cirrhosis. Am J Med. 2012 Oct;125(10):1019-25. doi: 10.1016/j.amjmed.2012.03.012. Epub 2012 Jul 24. PubMed PMID: 22835465; PubMed Central PMCID: PMC3932181.
Quinney SK, Malireddy SR, Vuppalanchi R, Hamman MA, Chalasani N, Gorski JC, Hall SD. Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin. Eur J Clin Pharmacol. 2013 Mar;69(3):439-48. doi: 10.1007/s00228-012-1339-x. Epub 2012 Jul 10. PubMed PMID: 22777148; PubMed Central PMCID: PMC3712509.
Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide. Dig Dis Sci. 2013 May;58(5):1415-21. doi: 10.1007/s10620-012-2493-9. Epub 2012 Dec 5. Review. PubMed PMID: 23212393; PubMed Central PMCID: PMC3826911.
Chatrath H, Berman K, Vuppalanchi R, Slaven J, Kwo P, Tector AJ, Chalasani N, Ghabril M. De novo malignancy post-liver transplantation: a single center, population controlled study. Clin Transplant. 2013 Jul-Aug;27(4):582-90. doi: 10.1111/ctr.12171. Epub 2013 Jun 30. PubMed PMID: 23808800; PubMed Central PMCID: PMC3740024.
Tandra S, Chalasani N, Jones DR, Mattar S, Hall SD, Vuppalanchi R. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients. Ann Surg. 2013 Aug;258(2):262-9. doi: 10.1097/SLA.0b013e31827a0e82. PubMed PMID: 23222033.
Vuppalanchi R, Liang T, Goswami CP, Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC, Chalasani N. Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis. PLoS One. 2013;8(9):e74471. doi: 10.1371/journal.pone.0074471. eCollection 2013. PubMed PMID: 24058572; PubMed Central PMCID: PMC3772944.
Hu S, Ghabril M, Amet T, Hu N, Byrd D, Yang K, Vuppalanchi R, Saxena R, Desai M, Lan J, Johnson R, Gupta S, Chalasani N, Yu Q. HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects. PLoS One. 2014;9(2):e86964. doi: 10.1371/journal.pone.0086964. eCollection 2014. PubMed PMID: 24516541; PubMed Central PMCID: PMC3916319.
Vuppalanchi R, Lindor K. Magic wand and crystal ball for primary sclerosing cholangitis. Gastroenterology. 2014 Apr;146(4):890-2. doi: 10.1053/j.gastro.2014.02.021. Epub 2014 Feb 22. PubMed PMID: 24566106.
Ghabril M, Vuppalanchi R. Drug-induced nodular regenerative hyperplasia. Semin Liver Dis. 2014 May;34(2):240-5. doi: 10.1055/s-0034-1375963. Epub 2014 May 31. Review. PubMed PMID: 24879987.
Vuppalanchi R, Gotur R, Reddy KR, Fontana RJ, Ghabril M, Kosinski AS, Gu J, Serrano J, Chalasani N. Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1550-5. doi: 10.1016/j.cgh.2013.12.016. Epub 2013 Dec 20. PubMed PMID: 24362054; PubMed Central PMCID: PMC4065228.
Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014 Oct;60(4):1399-408. doi: 10.1002/hep.27317. Epub 2014 Aug 25. PubMed PMID: 25043597; PubMed Central PMCID: PMC4293199.
Vuppalanchi R, Jain AK, Deppe R, Yates K, Comerford M, Masuoka HC, Neuschwander-Tetri BA, Loomba R, Brunt EM, Kleiner DE, Molleston JP, Schwimmer JB, Lavine JE, Tonascia J, Chalasani N. Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014 Dec;12(12):2121-30.e1-2. doi: 10.1016/j.cgh.2014.05.010. Epub 2014 May 17. PubMed PMID: 24846279; PubMed Central PMCID: PMC4830682.
Bell LN, Wulff J, Comerford M, Vuppalanchi R, Chalasani N. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis. Liver Int. 2015 Jan;35(1):263-74. doi: 10.1111/liv.12680. Epub 2014 Sep 22. PubMed PMID: 25181933; PubMed Central PMCID: PMC4293304.
Martinez MA, Vuppalanchi R, Fontana RJ, Stolz A, Kleiner DE, Hayashi PH, Gu J, Hoofnagle JH, Chalasani N. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol. 2015 Feb;13(2):369-376.e3. doi: 10.1016/j.cgh.2014.07.054. Epub 2014 Aug 9. PubMed PMID: 25111234; PubMed Central PMCID: PMC4321982.
Martinez M, Tandra A, Vuppalanchi R. Reply: To PMID 24395623. Hepatology. 2015 Jun;61(6):2119-20. doi: 10.1002/hep.27542. Epub 2015 Apr 18. PubMed PMID: 25266638.
Force J, Saxena R, Schneider BP, Storniolo AM, Sledge GW Jr, Chalasani N, Vuppalanchi R. Nodular Regenerative Hyperplasia After Treatment With Trastuzumab Emtansine. J Clin Oncol. 2016 Jan 20;34(3):e9-12. doi: 10.1200/JCO.2013.49.8543. Epub 2014 Apr 28. PubMed PMID: 24778392.
Vuppalanchi R, Chalasani N. Screening Strategies for Nonalcoholic Steatohepatitis in High-Risk Individuals: Trimming Away the Fat. Dig Dis Sci. 2016 Jul;61(7):1790-2. doi: 10.1007/s10620-016-4134-1. PubMed PMID: 27010545.
Zheng EX, Rossi S, Fontana RJ, Vuppalanchi R, Hoofnagle JH, Khan I, Navarro VJ. Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study. Drug Saf. 2016 Aug;39(8):749-54. doi: 10.1007/s40264-016-0428-7. PubMed PMID: 27189593; PubMed Central PMCID: PMC4961850.
Eddowes P, Sasso M, Fournier C, Vuppalanchi R, Newsome P. Steatosis and liver stiffness measurements using transient elastography. Hepatology. 2016 Aug;64(2):700. doi: 10.1002/hep.28515. Epub 2016 Apr 4. PubMed PMID: 26928747.
What would you like to do?